Advances in diabetes for the millennium: Drug therapy of type 2 diabetes CME

Marc Rendell

Research output: Contribution to journalArticle

11 Scopus citations

Abstract

There are many new orally administered agents to treat type 2 diabetes. Sulfonylureas and meglitinides stimulate insulin secretion. Metformin has been joined by thiazolidinediones to reduce insulin resistance. Disaccharidase inhibitors slow glucose uptake after a meal. Beta-3 agonists and agents that augment glucagon-like peptide activity are promising new agents in the effort to not only control glucose levels but also restrain weight gain. The future treatment of diabetes will require multiple drugs working in concert to normalize blood glucose.

Original languageEnglish (US)
JournalMedGenMed Medscape General Medicine
Volume6
Issue number3 SUPPL.
StatePublished - Dec 1 2004

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Fingerprint Dive into the research topics of 'Advances in diabetes for the millennium: Drug therapy of type 2 diabetes CME'. Together they form a unique fingerprint.

  • Cite this